Skip to main content

Medications for Tardive Dyskinesia

The medications listed below are related to or used in the treatment of this condition.

Filter
Drug name Rating Reviews Activity ? Rx/OTC Pregnancy CSA Alcohol
valbenazine 4.9 14 reviews for valbenazine to treat Tardive Dyskinesia
Rx N X
Generic name:
valbenazine systemic
Brand name:
Ingrezza
Drug class:
VMAT2 inhibitors
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph
Ingrezza 4.6 13 reviews for Ingrezza to treat Tardive Dyskinesia
Rx N X
Generic name:
valbenazine systemic
Drug class:
VMAT2 inhibitors
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
deutetrabenazine 4.8 11 reviews for deutetrabenazine to treat Tardive Dyskinesia
Rx N X
Generic name:
deutetrabenazine systemic
Brand names:
Austedo, Austedo XR
Drug class:
VMAT2 inhibitors
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph
Austedo 5.7 9 reviews for Austedo to treat Tardive Dyskinesia
Rx N X
Generic name:
deutetrabenazine systemic
Drug class:
VMAT2 inhibitors
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
tetrabenazine Off-label 4.5 3 reviews for tetrabenazine to treat Tardive Dyskinesia
Rx C N X
Generic name:
tetrabenazine systemic
Drug class:
VMAT2 inhibitors
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
Off-label:
Yes
vitamin e 1.0 1 review for vitamin e to treat Tardive Dyskinesia
Rx/OTC C N
Generic name:
vitamin e systemic
Brand names:
Aquasol E, Alpha E, Aqua Gem-E, E-400 Clear, E-600, E-Gems, E Pherol
Drug class:
vitamins
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Natural Product Monographs
Alpha E Rate Add review
Rx/OTC C N
Generic name:
vitamin e systemic
Drug class:
vitamins
For consumers:
dosage, interactions, side effects
amantadine Rate Add review
Rx C N
Generic name:
amantadine systemic
Drug class:
adamantane antivirals, dopaminergic antiparkinsonism agents
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
apomorphine Off-label Rate Add review
Rx C N X
Generic name:
apomorphine systemic
Drug class:
dopaminergic antiparkinsonism agents
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
Off-label:
Yes
Aqua Gem-E Rate Add review
Rx/OTC C N
Generic name:
vitamin e systemic
Drug class:
vitamins
For consumers:
dosage, interactions, side effects
Aquasol E Rate Add review
Rx/OTC C N
Generic name:
vitamin e systemic
Drug class:
vitamins
For consumers:
dosage, interactions, side effects
Austedo XR Rate Add review
Rx N X
Generic name:
deutetrabenazine systemic
Drug class:
VMAT2 inhibitors
For consumers:
dosage, interactions, side effects
bromocriptine Off-label Rate Add review
Rx B N X
Generic name:
bromocriptine systemic
Drug class:
dopaminergic antiparkinsonism agents, prolactin inhibitors
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
Off-label:
Yes
chlordiazepoxide Off-label Rate Add review
Rx N 4 X
Generic name:
chlordiazepoxide systemic
Drug class:
benzodiazepines
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
Off-label:
Yes
clonidine Off-label Rate Add review
Rx C N X
Generic name:
clonidine systemic
Drug class:
antiadrenergic agents, centrally acting
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
Off-label:
Yes
E-400 Clear Rate Add review
Rx/OTC C N
Generic name:
vitamin e systemic
Drug class:
vitamins
For consumers:
dosage, interactions, side effects
E-600 Rate Add review
Rx/OTC C N
Generic name:
vitamin e systemic
Drug class:
vitamins
For consumers:
dosage, interactions, side effects
E-Gems Rate Add review
Rx/OTC C N
Generic name:
vitamin e systemic
Drug class:
vitamins
For consumers:
dosage, interactions, side effects
E Pherol Rate Add review
Rx/OTC C N
Generic name:
vitamin e systemic
Drug class:
vitamins
For consumers:
dosage, interactions, side effects
pramipexole Off-label Rate Add review
Rx C N X
Generic name:
pramipexole systemic
Drug class:
dopaminergic antiparkinsonism agents
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
Off-label:
Yes
propranolol Off-label Rate Add review
Rx C N X
Generic name:
propranolol systemic
Drug class:
non-cardioselective beta blockers, group II antiarrhythmics
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
Off-label:
Yes
pyridoxine Rate Add review
Rx/OTC C N
Generic name:
pyridoxine systemic
Drug class:
vitamins
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
ropinirole Off-label Rate Add review
Rx C N X
Generic name:
ropinirole systemic
Drug class:
dopaminergic antiparkinsonism agents
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
Off-label:
Yes

Frequently asked questions

View more FAQ

Learn more about Tardive Dyskinesia

Care guides

Medicine.com guides (external)

Legend

Rating For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective).
Activity Activity is based on recent site visitor activity relative to other medications in the list.
Rx Prescription only.
OTC Over-the-counter.
Rx/OTC Prescription or Over-the-counter.
Off-label This medication may not be approved by the FDA for the treatment of this condition.
EUA An Emergency Use Authorization (EUA) allows the FDA to authorize unapproved medical products or unapproved uses of approved medical products to be used in a declared public health emergency when there are no adequate, approved, and available alternatives.
Expanded Access Expanded Access is a potential pathway for a patient with a serious or immediately life-threatening disease or condition to gain access to an investigational medical product (drug, biologic, or medical device) for treatment outside of clinical trials when no comparable or satisfactory alternative therapy options are available.
Pregnancy Category
A Adequate and well-controlled studies have failed to demonstrate a risk to the fetus in the first trimester of pregnancy (and there is no evidence of risk in later trimesters).
B Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women.
C Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use in pregnant women despite potential risks.
D There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use in pregnant women despite potential risks.
X Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use in pregnant women clearly outweigh potential benefits.
N FDA has not classified the drug.
Controlled Substances Act (CSA) Schedule
M The drug has multiple schedules. The schedule may depend on the exact dosage form or strength of the medication.
U CSA Schedule is unknown.
N Is not subject to the Controlled Substances Act.
1 Has a high potential for abuse. Has no currently accepted medical use in treatment in the United States. There is a lack of accepted safety for use under medical supervision.
2 Has a high potential for abuse. Has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse may lead to severe psychological or physical dependence.
3 Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence.
4 Has a low potential for abuse relative to those in schedule 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 3.
5 Has a low potential for abuse relative to those in schedule 4. Has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 4.
Alcohol
X Interacts with Alcohol.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.